logo
Select company
Select metric
9.78%Debt to Assets Ratio
VS
Market
65
Sector
56
Industry
43
History
5
$ 5.86Close
$ 1.93 - $ 6.17 52-Week Range
Ticker Information

Ticker

ABCL

Company Name

ABCELLERA BIOLOGICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABCELLERA BIOLOGICS INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABCL - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 1.4B$ 137.18M9.78%
3/31/2025$ 1.34B$ 63.21M4.7%
12/31/2024$ 1.36B$ 60.74M4.46%
9/30/2024$ 1.39B$ 66.27M4.76%
6/30/2024$ 1.41B$ 66.45M4.7%
3/31/2024$ 1.46B$ 68.08M4.65%
12/31/2023$ 1.49B$ 71.22M4.79%
9/30/2023$ 1.51B$ 75.19M4.97%
6/30/2023$ 1.54B$ 78.08M5.08%
3/31/2023$ 1.5B$ 77.27M5.16%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABCELLERA BIOLOGICS INC's latest trailing twelve months (TTM) Debt to Assets stands at 25.91%.
  • Over the past 5 years, ABCELLERA BIOLOGICS INC's average Debt to Assets has been 5.07%.
  • The median Debt to Assets for ABCELLERA BIOLOGICS INC during this period was 4.65%
  • ABCELLERA BIOLOGICS INC reached its highest Debt to Assets over the past 5 years at 25.91%.
  • The lowest Debt to Assets recorded by ABCELLERA BIOLOGICS INC in the same timeframe 0.61%

ABCELLERA BIOLOGICS INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
MGTX : MEIRAGTX HOLDINGS PLC 40.49%AUTL : AUTOLUS THERAPEUTICS PLC 43.71%NTLA : INTELLIA THERAPEUTICS INC 11.41%TNGX : TANGO THERAPEUTICS INC 14.72%FENC : FENNEC PHARMACEUTICALS INC 40.32%GOSS : GOSSAMER BIO INC 83.82%SSII : SS INNOVATIONS INTERNATIONAL INC 13.99%VIR : VIR BIOTECHNOLOGY INC 7.83%CCCC : C4 THERAPEUTICS INC 21.22%IMNM : IMMUNOME INC 1.4%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for ABCELLERA BIOLOGICS INC is calculated as follows: Debt [ $ 6.08M ] / Assets [ $ 23.49M ]
(=) Debt to Assets [ 25.91% ]

ABCL - Debt to Assets Ratio, Last 5 years

0.61%

Minimum

Dec 31, 2020

25.91%

Maximum

Dec 31, 2019

5.07%

Average

4.65%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.51%